Abstract:Objective To systematically summarize the criteria, risk factors and clinical predictors of high ovarian response, thus providing scientific basis and support for setting judgement and prediction criteria of high ovarian response. Methods We systematically searched PubMed, EMBASE, CBM, CNKI, Wanfang Data and clinical practice guideline database including National Guideline Clearinghouse (NGC), National Institute of Clinical Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and so on, for eligible records from inception to January 2018. Two well-trained reviewers who had full understanding of the study protocol conducted the literature screening, risk of bias assessment and data extraction independently. Then the information of criteria, risk factors were summarized and analyzed, and clinical predictors of high ovarian response were collected. Results Totally 35 records were identified for analysis, including 25 original studies, 8 reviews and 2 Meta-analyses. For criteria of high ovarian response, the most frequently used single indexes were over 15 oocytes retrieved at oocyte pick-up, estradiol level between 14 680 pmol/L and 18 350 pmol/L on the day of human chorionic gonadotropin (hCG) injection, or ovarian sensitivity index (OSI)>10.07/IU. The most common condition in which two or more indexes combined were oocytes retrieved over 15 or 20 and/or peak estradiol concentration on hCG injection day over 11 010 pmol/L. As for risk factors, results from multiple-factor analysis showed that patients with antral follicle count (AFC)≥11, testosterone≥0.299 5 μg/L or peak estradiol≥15.355 μg/L were tend to have high ovarian response. As for clinical predictors, results from cohort studies and reviews showed that the most effective cutoff value for prediction of high ovarian response were anti-Mullerian hormone (AMH)>3.04 μg/L or AMH≥3.12 μg/L, or AFC>14. And studies included in Meta-analysis commonly used AMH>1.59-7.00 μg/L or AFC>9-18 to predict high ovarian response. Moreover, results of Meta-analysis suggested that on basis of age, combing follicle stimulating hormone (FSH), AMH or AFC could improve the performance of prediction. AMH and AFC were better than FSH as predictors of high ovarian response. Combining AMH and AFC to predict high ovarian response would be more accurate than using them separately. Using AFC plus AMH to predict high ovarian response resulted in similar accuracy as using age plus AFC and AMH. Conclusion Current available evidence showed that the most commonly used criteria were oocytes retrieved over 15 or 20 and/or peak estradiol concentration on hCG injection day over 11 010 pmol/L. AFC≥11, testosterone≥0.299 5 μg/L, peak estradiol≥15.355 μg/L may be risk factors for high ovarian response. Based on age, combing FSH, AMH or AFC could improve the performance of prediction. AMH and AFC were better than FSH as predictors of high ovarian response. Combining AMH and AFC to predict high ovarian response would be more accurate than using them separately. Using AFC plus AMH to predict high ovarian response resulted in similar accuracy as using age plus AFC and AMH. However, there were no uniform criteria worldwide for identifying or predicting high ovarian response, studies applying method such as expert consensus based on current results to set uniform criteria and clinical predictors of high ovarian response are warranted to provide theoretical basis and reference for relative study design and guideline development in the future. Key words: High ovarian response; Fertilization in vitro; Embryo transfer; Controlled ovarian hyperstimulation; Predictors; Judgement criteria; Meta-analysis

Study on the Multi-Factors of Poor Ovarian Response in Vitro Fertilization and Embryo-Transfer

Clinical analysis on 309 cases of poor ovarian response in in vitro fertilization-embryo transfer

Factors Affecting the Live-Birth Rate in Women with Diminished Ovarian Reserve Undergoing IVF-ET

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Factors Influencing Ovarian Response during In Vitro Fertilization and Embryo Transfer

Study of predictive indicators and pregnancy outcome of poor ovarian response in controlled ovarian hyper-stimulation

Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders

The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples

The Evaluative Effectiveness of a Combined Index Exceeded That of a Single Variable for the Ovarian Reserve and Response of Infertile Women

The Comparison of Evaluative Effectiveness Between Antral Follicle Count/age Ratio and Ovarian Response Prediction Index for the Ovarian Reserve and Response Functions in Infertile Women

The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient

Evaluating the predictive value of age,AFC and bFSH on ovarian reserve function by receiver operating characteristic analysis

Influence of ovarian high response on pregnancy outcome of in vitro fertilization and embryo transfer

Criteria and Clinical Predictors of High Ovarian Response: a Systematic Review

The Predication of the Results of in Vitro Fertilization and Embryo Transfer by the Ratio of Basal FSH and LH Level

Analyze the clinical outcome of poor responders in IVF-ET

Poor Response in Controlled Ovarian Hyperstimulation during IVF-ET

Factors improved clinical outcomes in patients < 38 years with diminished ovarian reserve and low oocyte retrieval: a retrospective study

M005 ANALYSIS OF CLINICAL FACTORS ON PREGNANCY LOSS DURING IVF‐ET TREATMENT

Clinical factors associated with unexpected poor or suboptimal response in Poseidon criteria patients

Predictive value of POSEIDON classification index for the early outcome of in vitro fertilization/intracytoplasmic sperm injection in the expected low prognosis population